TickerGuard
Buy Day today: Neutral (47) Mixed market breadth · no major macro event
ENOV

Enovis Corp

Healthcare · Medical Devices

17.60$ -3.2% vs. previous close Closing price · As of: Oct 7, 2026

Statements

Balance Sheet

Enovis Corp (ENOV) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 3,766 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ENOV
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
6,542 6,385 6,430 6,730 6,838 6,722 6,879 6,463 6,446 6,604 10,502 9,899 9,591 7,387 7,456 7,123 7,154 7,352 8,067 7,559 7,972 8,516 8,484 4,504 4,445 4,273 4,300 4,444 4,401 4,509 5,479 5,442 5,550 4,719 4,875 5,021 4,433 3,835 3,832 3,766
1,803 1,786 1,781 1,958 2,315 2,070 2,163 1,947 1,951 1,958 2,409 3,637 3,499 1,404 1,582 1,228 1,288 1,362 2,078 1,479 1,726 2,303 2,348 1,078 1,008 795 833 887 854 897 1,151 1,173 1,203 1,146 1,218 1,280 1,280 1,207 1,240 1,215
192 222 208 272 260 262 268 258 286 245 242 132 127 110 366 66 66 101 764 62 177 680 662 96 55 24 22 32 32 36 66 35 35 48 38 44 34 36 33 13
192 222 208 272 260 412 403 258 286 245 242 132 127 110 366 66 66 101 764 62 177 680 662 359 255 24 22 32 32 36 66 35 35 48 38 44 34 36 33 13
922 914 901 979 957 970 993 986 954 989 1,153 616 576 562 499 450 498 517 554 600 603 255 657 255 259 267 281 299 277 291 381 395 400 407 436 454 432 443 444 442
424 404 427 455 415 430 499 490 484 497 740 595 584 572 562 557 536 565 606 664 781 356 853 401 417 427 439 454 471 469 586 615 610 547 586 628 614 584 603 602
– – – – – – – – – – – – – – – – – – 650 643 670 521 505 298 225 237 246 261 324 – – – – – – – – – – –
2,632 2,563 2,588 2,687 2,527 2,539 2,612 2,505 2,524 2,577 3,852 2,822 2,784 3,203 3,191 3,210 3,245 3,315 3,332 3,399 3,497 1,934 3,441 1,925 1,960 1,984 1,987 2,034 2,027 2,061 2,415 2,353 2,394 1,693 1,733 1,781 1,219 718 712 710
941 899 930 950 936 1,017 1,016 960 941 1,013 2,871 2,314 2,262 1,719 1,648 1,651 1,636 1,663 1,653 1,678 1,727 1,154 1,637 1,114 1,117 1,111 1,082 1,111 1,101 1,127 1,408 1,380 1,396 1,317 1,345 1,342 1,281 1,237 1,192 1,150
3,374 3,292 3,218 3,358 3,325 2,994 3,038 2,925 2,968 3,127 6,761 6,643 6,458 3,897 4,118 3,727 3,697 3,764 3,776 3,208 3,342 3,854 3,840 1,012 1,037 823 854 993 959 1,089 2,168 2,153 2,217 2,154 2,255 2,440 2,410 2,343 2,353 2,287
1,075 1,107 1,082 1,147 1,289 1,097 1,095 1,075 1,069 1,199 1,572 1,599 1,506 857 819 759 785 812 1,558 899 975 1,024 1,450 813 854 565 349 354 355 370 549 518 530 529 477 568 575 598 609 612
6.1 5.4 5.9 5.9 5.9 5.8 6.1 6.2 6.4 5.0 181 74 66 68 65 66 67 67 765 57 50 30 462 472 473 244 23 22 21 22 43 37 42 42 42 43 44 60 60 63
652 480 608 646 544 587 579 586 564 236 706 400 376 360 368 299 306 330 407 454 472 155 538 159 180 136 152 147 125 132 156 160 158 179 188 212 199 188 214 194
– – – – – – – – – – – – – – – – – – 1,482 1,577 1,612 2,079 1,648 – – 40 285 400 395 466 1,318 1,329 1,325 1,309 1,368 1,374 1,340 1,262 1,291 1,247
2,973 2,897 3,010 3,163 3,300 3,500 3,605 3,316 3,262 3,270 3,578 3,095 2,982 3,441 3,291 3,352 3,412 3,543 4,247 4,308 4,587 4,617 4,600 3,489 3,407 3,448 3,443 3,449 3,440 3,418 3,308 3,286 3,330 2,562 2,618 2,578 2,021 1,490 1,477 1,477
648 685 734 787 833 846 876 915 946 992 955 486 496 480 479 471 484 517 536 565 591 589 604 681 614 576 552 542 540 542 470 452 420 -283 -339 -376 -947 -1,467 -1,476 -1,477
41 41 41 41 41 41 41 41 39 39 45 46 46 47 47 46 46 46 47 51 53 64 54 55 54 54 54 55 55 55 55 55 56 58 57 57 57 57 57 58

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?